Category: MARKETS BY DIEGO

ASSET ANALYSIS

Analysis and Opinion: Adaptimmune Therapeutics ($ADAP) — Pipeline Sales, Rolling BLA, and the Race Against Delisting

August 10, 2026

MARKETS BY DIEGO

Analysis and Opinion: Amper ($APE) — Teltronic, the European Rebuild, and the Small-Cap Stock That Is No Longer One

July 30, 2026

MARKETS BY DIEGO

Analysis and Opinion: Indra Sistemas ($IDR) — Record Portfolio, Net Cash, and the Resolution of the CNMV Issue

July 9, 2026

MSFU QUOTATION 04/05-01/06

OPERATIONAL PERFORMANCE

ANATOMY OF AN ASYMMETRICAL POSITION ON MICROSOFT: CALLS ON MSFU

June 9, 2026

ASSET ANALYSIS

Five key areas: energy, computing, and the infrastructure that supports AI

June 9, 2026

ASSET ANALYSIS

Analysis and Opinion by Diego García del Río: Microsoft Corporation ($MSFT)

May 12, 2026

ASSET ANALYSIS

Analysis and Opinion: Aurinia Pharma ($AUPH) — Lupkynis, Aritinercept, and the Flexibility of the Autoimmune Pipeline

April 23, 2026

ASSET ANALYSIS

Analysis and Opinion: Rocket Pharmaceuticals ($RCKT) — Gene Therapy, KRESLADI™, and the PDUFA Deadline of 2026

April 20, 2026

OPERATIONAL PERFORMANCE

Energy Positioning Amid a Shift in the Geopolitical Balance: An Analysis of a Call Option on Brent (+769%)

April 6, 2026

MARKET STRATEGIES

Volatility Convexity Strategy and Strategic Construction of Nasdaq Exposure

March 10, 2026

There are no more posts to displayThere are no more articles to display.

LATEST PUBLICATION

ADAP 1

Analysis and Opinion: Adaptimmune Therapeutics ($ADAP) — Pipeline Sales, Rolling BLA, and the Race Against Delisting

2 weeks ago

In this analysis: What is Adaptimmune and why does it matter? Earnings Analysis, Balance Sheet, Catalysts, Options Analysis, Short Positions, Insiders, and Institutions; Summary; Asset Analysis · October 2025 Analysis and Opinion: Adaptimmune Therapeutics ($ADAP) — Pipeline Sale,...

Read More

MORE PUBLICATIONS

MARKETS BY DIEGO

Analysis and Opinion: Amper ($APE) — Teltronic, the European Rebuild, and the Small-Cap Stock That Is No Longer One

4 weeks ago

Read More

MARKETS BY DIEGO

Analysis and Opinion: Indra Sistemas ($IDR) — Record Portfolio, Net Cash, and the Resolution of the CNMV Issue

2 months ago

Read More

MSFU QUOTATION 04/05-01/06

OPERATIONAL PERFORMANCE

ANATOMY OF AN ASYMMETRICAL POSITION ON MICROSOFT: CALLS ON MSFU

3 months ago

Read More

Five key areas: energy, computing, and the infrastructure that supports AI

3 months ago

Read More

Analysis and Opinion by Diego García del Río: Microsoft Corporation ($MSFT)

3 months ago

Read More

Analysis and Opinion: Aurinia Pharma ($AUPH) — Lupkynis, Aritinercept, and the Flexibility of the Autoimmune Pipeline

4 months ago

Read More

Analysis and Opinion: Rocket Pharmaceuticals ($RCKT) — Gene Therapy, KRESLADI™, and the PDUFA Deadline of 2026

4 months ago

Read More

WhatsApp Image 2026 04 06 at 13.01.49 1 edited

OPERATIONAL PERFORMANCE

Energy Positioning Amid a Shift in the Geopolitical Balance: An Analysis of a Call Option on Brent (+769%)

5 months ago

Read More

MARKET STRATEGIES

Volatility Convexity Strategy and Strategic Construction of Nasdaq Exposure

6 months ago

Read More

MARKETS BY DIEGO

Analysis and Opinion: Candel Therapeutics ($CADL) — Viral Immunotherapy, CAN-2409, and the BLA That Will Define 2026

6 months ago

Read More

Analysis and Opinion: Verisure Plc ($VSURE) — Recurring ARR, deleveraging, and the post-IPO correction

7 months ago

Read More

Analysis and Opinion: Izertis S.A. ($IZER) — Technology Consulting Firm, the Izertis 2030 Plan, and the Growth Thesis

7 months ago

Read More

OPERATIONAL PERFORMANCE

When the Market Defies Logic: A Look at the «Broken Equilibrium» and Asymmetric Hedging with Leveraged ETFs

7 months ago

Read More

Analysis and Opinion: Bolloré ($BOLL) and Cirsa Enterprises ($CIRSA) — Value Investing and Regulated Growth in Europe

8 months ago

Read More

Trading in biopharma stocks: results of one of my strategies

9 months ago

Read More

OPERATIONAL PERFORMANCE

REACTIVATING SMART HEDGING: LEVERAGED ETF OPTIONS STRATEGY

9 months ago

Read More

MARKETS BY DIEGO

Analysis and Opinion: Zegona Communications Plc ($ZEG) — Vodafone Spain, Buy-Fix-Sell, and the Restructuring Thesis

9 months ago

Read More

MARKETS BY DIEGO

Analysis and Opinion: TMC the metals company Inc. ($TMC) — Critical Metals, Underwater Mining, and the CCZ Thesis

9 months ago

Read More

MARKETS BY DIEGO

Analysis and Opinion: Dyne Therapeutics Inc. ($DYN) — the FORCE™ platform, DMD/DM1, and the fast-track approval thesis

9 months ago

Read More

MARKETS BY DIEGO

Analysis and Opinion: $IOVA, $GANX, and $GOSS — TIL therapies, allosteric molecules, and seralutinib in clinical trials

10 months ago

Read More

FedWatch Tool | CME Group

MARKETS BY DIEGO

Short position in leveraged inverse ETF options in anticipation of a potential market correction

10 months ago

Read More

ANALYSIS OF $WTI, $OWL, AND $MELI

MARKETS BY DIEGO

Analysis and Opinion: W&T Offshore ($WTI) and MercadoLibre ($MELI) — Value in Offshore E&P and Growth in the Latin American Digital Ecosystem

10 months ago

Read More

The Fed's Decision: A Likely Cut Amid Weak Data

MARKETS BY DIEGO

Extreme Compression Week: Four Critical Nodes Converge in the Global Market

10 months ago

Read More

image 19 e1760469017541

MARKET STRATEGIES

Hedging with Options on Indexed and Leveraged ETFs against Short Futures Positioning Strategy

10 months ago

Read More

image 15 e1760466880844

The Broken Equilibrium: How AI Euphoria and Leverage Have Pushed the Market to the Limit - By Diego García del Río

11 months ago

Read More

SPX Options Analysis: Positive Gamma Structure and Volatility in Contango - 06/10/2025

SPX Options Analysis: Positive Gamma Structure and Volatility in Contango - 06/10/2025

11 months ago

Read More

Trump Faces His Third Shutdown: Potential Impact on Wall Street - By Diego García del Río

11 months ago

Read More

CRNX COVER 2

OPERATIONAL PERFORMANCE

Options Performance on $CRNX - By Diego Garcia del Rio

11 months ago

Read More

ACHV ZVRA CRNX 1

ANALYSIS AND OPINION BY DIEGO GARCÍA DEL RÍO: $ACHV, $ZVRA AND $CRNX - 09/23/2025

11 months ago

Read More

CALL WALL 6600 3

SPX Options Analysis: Concentrated Gamma and Correction Risk towards 08 DTE by Diego Garcia del Rio - 09/22/2025

11 months ago

Read More

LET'S TALK